NSE sought clarification from several listed companies regarding media reports

Traders Union
All News
Financial News
NSE sought clarification from companies

Highlights

The exchange sent a letter to Gensol Engineering Limited on July 13, 2026, regarding media reports that IREDA declared its Rs 673 crore loan as fraudulent.
The exchange sent letters to IDBI Bank Limited, JSW Dulux Limited, Shadowfax Technologies Limited, and Zydus Lifesciences Limited seeking clarification on media reports about major transactions, offers, and court orders.
NSE's initiative of sending these letters is a step towards increasing transparency on sensitive news in the market and protecting investors' interests.

This article was translated from the original. Read the original version by our correspondent here.

Exchange Investigation and Requested Responses

According to the National Stock Exchange of India, the exchange has sent letters to several companies to verify the authenticity of recent media reports, aiming to provide clear information to the market and safeguard investors' interests. This action was taken following news related to Gensol Engineering Limited, IDBI Bank Limited, JSW Dulux Limited, Shadowfax Technologies Limited, and Zydus Lifesciences Limited.

In the case of Gensol Engineering Limited, media reports stated that IREDA has declared the company's Rs 673 crore loan as fraudulent and reported it to the RBI. The exchange sent a letter to the company on July 13, 2026, seeking confirmation or denial of this report.

Regarding IDBI Bank Limited, media reports indicated that the government is close to accepting Fairfax Financial's revised proposal. In this matter, the exchange has written to the company and is awaiting its response.

For JSW Dulux Limited, media reports claimed that Akzo Nobel rejected Nippon's $8.6 billion offer for its paint business. The exchange sent a letter to the company on July 13, 2026, seeking clarification.

In the case of Shadowfax Technologies Limited, media reports stated that Flipkart may sell a stake worth about Rs 700 crore in the company. The exchange has contacted the company to verify the accuracy of this information.

Market Transparency and Impact on Investors

Reports related to Zydus Lifesciences Limited stated that the Delhi High Court has temporarily halted the supply of Zydus's cancer drug Ikra in the AbbVie patent dispute. In this case as well, the exchange has written to the company and is awaiting its response.

In all these cases, the exchange's action demonstrates that formal clarification on sensitive news in the market is being prioritized. Such processes help limit the impact of unverified information about listed companies and assist investors in making decisions on a more reliable basis.

Our previous report on NSE seeking clarification from several listed companies regarding unusual price/volume activity and certain media reports mentioned that the exchange had sent letters to relevant companies to provide timely and relevant information to investors. That exercise also referenced verification/response requests regarding the IREDA loan allegations against Gensol Engineering, acquisition talks involving Happiest Minds, and news related to Akzo Nobel's paint business.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.